Tandem Diabetes Care Executive and Leadership Team

John Sheridan, the President & Chief Executive Officer at Tandem Diabetes Care, directs the company's overarching strategy and operational execution. Sheridan guides the development and commercialization of innovative diabetes technology solutions, including the t:slim X2 insulin delivery system and the Tandem Mobi insulin pump. This leadership role involves setting the vision for market expansion, both domestically and internationally, ensuring the company remains at the forefront of automated insulin delivery systems. Sheridan's focus includes driving product innovation and fostering strategic partnerships to enhance patient outcomes. The Chief Executive Officer ensures alignment across all departments, from research and development to sales and marketing, to achieve sustained growth and market leadership. By overseeing critical business decisions, John Sheridan solidifies Tandem Diabetes Care's commitment to improving the lives of individuals managing diabetes through advanced technology.

Kim Blickenstaff, the President & Chief Executive Officer at Tandem Diabetes Care, spearheads the company's strategic direction and long-term vision. Blickenstaff's leadership encompasses the entire product lifecycle, from initial design and development to the global commercialization of cutting-edge diabetes management technology. This executive position involves cultivating a culture of innovation, particularly concerning automated insulin delivery systems like the t:slim X2 and Tandem Mobi. The Chief Executive Officer is responsible for driving market penetration in the United States and international territories, ensuring Tandem Diabetes Care's solutions reach individuals requiring advanced diabetes care. Blickenstaff's oversight extends to financial health and operational efficiency, crucial for sustaining the development of essential products such as insulin cartridges and infusion sets. Through strategic decision-making, Kim Blickenstaff champions the company's mission to empower individuals with diabetes through reliable and advanced technology.

John Cajigas, the Chief Financial Officer at Tandem Diabetes Care, manages the company's financial operations and fiscal strategy. Cajigas oversees all aspects of financial planning, accounting, and reporting, ensuring robust fiscal health for the organization. This critical role involves managing budgets, forecasting financial performance, and optimizing resource allocation to support the design, development, and commercialization of diabetes technology solutions. The Chief Financial Officer plays a key part in securing funding and managing investor relations, vital for the continued innovation of products like the t:slim X2 insulin delivery system and the Tandem Mobi insulin pump. Cajigas's responsibilities include ensuring compliance with financial regulations and driving efficiency across the company's operations. By maintaining strong financial discipline, John Cajigas supports Tandem Diabetes Care's mission to provide advanced diabetes management tools to individuals worldwide.

Leigh Vosseller, the Executive Vice President & Chief Financial Officer at Tandem Diabetes Care, directs the company's comprehensive financial strategy and management. Vosseller oversees all financial planning, accounting functions, and capital allocation to support the ongoing innovation and global distribution of Tandem Diabetes Care's advanced diabetes technology. This executive role is pivotal in ensuring the financial viability and growth of the company, particularly in relation to the development and sales of the t:slim X2 insulin delivery system and the Tandem Mobi insulin pump. The Chief Financial Officer is instrumental in managing budgets, analyzing financial performance, and identifying opportunities for fiscal optimization. Vosseller's responsibilities also include managing relationships with financial institutions and stakeholders, crucial for funding research and development of products like insulin cartridges and infusion sets. Through meticulous financial oversight, Leigh Vosseller enables Tandem Diabetes Care to advance its mission of improving lives for individuals with diabetes.

Susan Morrison, the Executive Vice President & Chief Administrative Officer at Tandem Diabetes Care, oversees critical administrative functions that support the company's operational efficiency and strategic objectives. Morrison directs human resources, legal affairs, and corporate compliance, ensuring a well-structured and compliant organizational framework. This leadership position is essential for managing the internal infrastructure that enables the design, development, and commercialization of innovative diabetes technology solutions, including the t:slim X2 insulin delivery system and the Tandem Mobi insulin pump. The Chief Administrative Officer plays a key role in fostering a productive work environment and managing corporate governance. Morrison's responsibilities extend to overseeing facilities management and ensuring seamless integration of administrative processes across all departments. By maintaining robust administrative operations, Susan Morrison supports Tandem Diabetes Care's commitment to delivering advanced diabetes management tools and improving patient outcomes globally.